This article needs additional citations for verification. (September 2012) (Learn how and when to remove this template message)
PT Kalbe Farma Tbk is a pharmaceutical, healthcare and nutrition company in North Jakarta, established in 1966. The Company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise. The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, distribution arm that reaches over 1 million outlets. Notably, the company produces misoprostol (sold under the brand name of Invitec), a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient (abortion-inducing substance).
|Founded||September 10, 1966|
|Cambodia, Malaysia, Myanmar, Philippines, Thailand, Vietnam, Sri Lanka, South Africa and Nigeria|
|Revenue||Rp 15.678 trillion (YTD Q3 2018)|
|Rp 1.834 trillion (YTD Q3 2018)|
|Total assets||Rp 17.531 trillion (YTD Q3 2018)|
Number of employees
|17,000 (YTD Q3 2018)|
Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Prenagen and Extra Joss.
Kalbe Farma was founded on September 10, 1966 by 6 siblings, Khouw Lip Tjoen, Khouw Lip Hiang, Khouw Lip Swan, Khouw Lip Boen (Also Known As: Dr. Boen, Boenjamin Setiawan), Maria Karmila, and F. Bing Aryanto. Kalbe Farma first began operations in a house garage that was owned by the founders.
In May 2020, Kalbe Farma signed a Memorandum of Understanding with South Korean pharmaceuticals company Genexine Inc. to develop a vaccine for the new corona virus or COVID-19.
- Grafton-Green, Patrick (1 October 2017). "Anti-abortion MP Jacob Rees-Mogg admits profits from abortion pills". Evening Standard. Retrieved 25 March 2020. CS1 maint: discouraged parameter (link)
- "Kalbe Farma and South Korea's Genexine to Start Human Trial for Covid-19 Vaccine". Jakarta Globe. Retrieved 2020-09-06.